Evidence map›Paper›PMID 40102238›Full record

ArticleGut microbes2025

Aruto Nakajima, Aleksandr A Arzamasov, Mikiyasu Sakanaka, Ryuta Murakami, Tomoya Kozakai, Keisuke Yoshida, Toshihiko Katoh, Miriam N Ojima, Junko Hirose, Saeko Nagao and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Synbiotic effects of 2'-fucosyllactose andFrontiers in nutrition · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aruto NakajimaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0002-5354-2394
Aleksandr A ArzamasovInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0002-4150-4817
Mikiyasu SakanakaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Ryuta MurakamiInnovative Research Institute, Morinaga Milk Industry Co, Ltd, Zama, Kanagawa, Japan.
Tomoya KozakaiGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Keisuke YoshidaInnovative Research Institute, Morinaga Milk Industry Co, Ltd, Zama, Kanagawa, Japan.
Toshihiko KatohGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Miriam N OjimaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Junko HiroseDepartment of Food and Nutrition, Kyoto Women's University, Kyoto, Japan.
Saeko NagaoNagao Midwife Clinic, Kyoto, Japan.
Jin-Zhong XiaoGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Toshitaka OdamakiGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Dmitry A RodionovInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0002-0939-390X
Takane KatayamaGraduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0003-4009-7874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fortifying infant formula with human milk oligosaccharides, such as 2'-fucosyllactose (2'-FL), is a global trend. Previous studies have shown the inability of pathogenic gut microbes to utilize 2'-FL. However, the present study demonstrates that the type strain (JCM 1290

Indexed as

BifidobacteriumClostridium perfringensTrisaccharidesBacterial ProteinsBacterial ToxinsCalcium-Binding ProteinsCoculture TechniquesFecesGastrointestinal MicrobiomeHumansInfantInfant FormulaLactoseMilk, HumanType C Phospholipases2'-fucosyllactosealpha toxin, Clostridium perfringensBacterial ProteinsBacterial ToxinsCalcium-Binding ProteinsLactoseTrisaccharidesType C Phospholipases2'-fucosyllactoseBifidobacteriaClostridium perfringensα-toxin

Identifiers

PMID40102238
PMCPMC11956901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.